PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Healthy Hearts for Women event marks 10 years of raising awareness

Healthy Hearts for Women event marks 10 years of raising awareness
2024-01-12
(Press-News.org) LEXINGTON, Ky. (Jan. 12, 2024) — The University of Kentucky will mark a decade of raising awareness and continuing its effort to warn women about the dangers of heart disease with the annual Healthy Hearts for Women Symposium.

Cardiovascular disease is the No. 1 killer of women, causing 1 in 3 deaths each year, according to the American Heart Association. Yet, only 44% of women recognize that cardiovascular disease is their greatest health threat.

“We see the evidence of this devastating statistic right here in Kentucky. The Commonwealth has the highest rates of deaths due to cardiovascular disease in women across the country,” said Analia Loria Kinsey, Ph.D., an associate professor in the Department of Pharmacology and Nutritional Sciences in the UK College of Medicine, who is one of the symposium organizers. 

"It’s important to recognize and understand the nuances of sex differences as we pursue better heart health,” said Yasir Alsiraj, Ph.D., pharmacology and nutritional sciences assistant professor and co-organizer of the symposium. “Through diligent research, we can work to create optimal treatments for women in Kentucky and the country.”

The symposium will also feature the following expert panelists:

Licy L. Yanes Cardozo, M.D., associate professor, University of Mississippi Medical Center
Hosted by the Department of Pharmacology and Nutritional Sciences Nina Stachenfeld, Ph.D., senior research scientist in obstetrics, gynecology and reproductive sciences, Yale University
Hosted by the Saha Cardiovascular Research Center Karol Watson, M.D., professor of medicine/cardiology, UCLA David Geffen School of Medicine
Hosted by Gill Heart and Vascular Institute Irene O. Aninye, Ph.D., chief science officer, Society for Women’s Health Research (SWHR)
Hosted by Women in Medicine and Science (WIMS) “Our hope with the Healthy Hearts for Women Symposium is to bring top-notch researchers to UK to share the latest research and efforts to help women live longer, healthier lives,” said Sanda Despa, Ph.D., pharmacology and nutritional sciences professor and symposium co-organizer.

The event will be held on Feb. 2 at 8 a.m. in room 127 of the Charles T. Wethington Building. Those wishing to attend can register online here.

The Healthy Hearts for Women Symposium is sponsored by the UK College of Medicine’s Department of Pharmacology and Nutritional Sciences as well as the Office of Diversity, Equity and Inclusion, the UK Gill Heart and Vascular Institute, Saha Cardiovascular Research Center and Women in Medicine and Science (WIMS).

UK HealthCare is the hospitals and clinics of the University of Kentucky. But it is so much more. It is more than 10,000 dedicated health care professionals committed to providing advanced subspecialty care for the most critically injured and ill patients from the Commonwealth and beyond. It also is the home of the state’s only National Cancer Institute (NCI)-designated Comprehensive Cancer Center, a Level IV Neonatal Intensive Care Unit that cares for the tiniest and sickest newborns, the region’s only Level 1 trauma center and Kentucky’s top hospital ranked by U.S. News & World Report.

As an academic research institution, we are continuously pursuing the next generation of cures, treatments, protocols and policies. Our discoveries have the potential to change what’s medically possible within our lifetimes. Our educators and thought leaders are transforming the health care landscape as our six health professions colleges teach the next generation of doctors, nurses, pharmacists and other health care professionals, spreading the highest standards of care. UK HealthCare is the power of advanced medicine committed to creating a healthier Kentucky, now and for generations to come. 

END

[Attachments] See images for this press release:
Healthy Hearts for Women event marks 10 years of raising awareness

ELSE PRESS RELEASES FROM THIS DATE:

Building trust and saving lives: A community approach to genetic education

Building trust and saving lives: A community approach to genetic education
2024-01-12
Changes to DNA, known as mutations, can increase the likelihood of developing cancer. Specifically, people with mutations in their BRCA 1 and 2 genes are substantially more likely to develop hereditary breast and ovarian cancers. But how do people know if they have these mutations? Genetic testing. Genetic testing allows doctors to see these microscopic changes. Knowing these mutations exist, doctors will check for signs of breast and ovarian cancers more often. Yet minorities, especially Black women, are less likely to participate in genetic testing. ...

Using idle trucks to power the grid with clean energy

2024-01-12
University of Waterloo researchers are tapping into idled electric vehicles to act as mobile generators and help power overworked and aging electricity grids. After analyzing energy demand on Alberta’s power grid during rush hour, the research proposes an innovative way to replenish electrical grids with power generated from fuel cells in trucks. “Canada’s power grids need to be upgraded,” said Dr. XiaoYu Wu, lead researcher and a professor in Waterloo’s Department of Mechanical and Mechatronics Engineering.  “But the price ...

Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma

Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma
2024-01-12
“Pazopanib is a multi-kinase inhibitor that is currently approved for treatment of advanced renal cell carcinoma and chemotherapy-refractory soft tissue sarcoma.” BUFFALO, NY- January 12, 2024 – A new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, “Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma.” Pazopanib, a multi-kinase VEGF inhibitor, is currently FDA approved for advanced renal cell carcinoma and advanced soft tissue sarcoma; but limited evidence exists on its efficacy in bone sarcomas. In this case report, researchers Mohamed A. Gouda, ...

3D in vitro human atherosclerosis model for high-throughput drug screening

3D in vitro human atherosclerosis model for high-throughput drug screening
2024-01-12
BIRMINGHAM, Ala. – A groundbreaking 3D, three-layer nanomatrix vascular sheet that possesses multiple features of atherosclerosis has been applied for developing a high-throughput functional assay of drug candidates to treat this disease, University of Alabama at Birmingham researchers report in the journal Biomaterials. “Current in vitro atherosclerosis models have significant limitations, including the lack of three-layer vascular architecture and limited atherosclerotic features,” said Ho-Wook Jun, Ph.D., a professor ...

The early bird (or scientist) gets the worm

The early bird (or scientist) gets the worm
2024-01-12
RIVERSIDE, Calif. -- Size does not matter. Certainly not when it comes to tiny worms securing the attention of biologists. One such biologist, Morris F. Maduro at the University of California, Riverside, has just been awarded a grant of nearly $1.3 million from the National Science Foundation, or NSF, to study a worm (or nematode) about a millimeter in length. The research project will focus on the gut of Pristionchus pacificus. Like most nematodes, P. pacificus develops quickly, its growth from embryo to adult taking just four days. It is a complete ...

News media trigger conflict for romantic couples with differing political views

News media trigger conflict for romantic couples with differing political views
2024-01-12
CHAMPAIGN, Ill. — By one estimate, as many as 30% of people in the U.S. are in romantic relationships with partners who do not share their political views. In today’s hyperpartisan climate, where Democrats and Republicans have difficulty talking to each other and their views are polarized about media outlets’ credibility, how do couples with differing political perspectives decide which media to follow? And how do these decisions affect their discussions on political issues and their relationship ...

Earth-sized planet discovered in ‘our solar backyard’

Earth-sized planet discovered in ‘our solar backyard’
2024-01-12
MADISON — A team of astronomers have discovered a planet closer and younger than any other Earth-sized world yet identified. It’s a remarkably hot world whose proximity to our own planet and to a star like our sun mark it as a unique opportunity to study how planets evolve. The new planet was described in a new study published this week by The Astronomical Journal. Melinda Soares-Furtado, a NASA Hubble Fellow at the University of Wisconsin–Madison who will begin work as an astronomy professor at the university in the fall, and recent UW–Madison graduate Benjamin Capistrant, now a graduate student at the University of Florida, co-led the study with co-authors from ...

NASA analysis confirms 2023 as warmest year on record

2024-01-12
Earth’s average surface temperature in 2023 was the warmest on record, according to an analysis by NASA. Global temperatures last year were around 2.1 degrees Fahrenheit (1.2 degrees Celsius) above the average for NASA’s baseline period (1951-1980), scientists from NASA’s Goddard Institute for Space Studies (GISS) in New York reported. “NASA and NOAA’s global temperature report confirms what billions of people around the world experienced last year; we are facing a climate ...

Incontinence could point to future disability

2024-01-12
If you are one of the 30% to 50% of women experiencing urinary incontinence, new research suggests that it could turn into a bigger health issue. Having more frequent urinary incontinence and leakage amounts is associated with higher odds of disability, according to RUSH researchers in a study published in the January issue of Menopause. “Often symptoms from urinary incontinence are ignored until they become bothersome or limit physical or social activities,” said Sheila Dugan, MD, chair of the Department of Physical Medicine and Rehabilitation at RUSH. “Because this study suggests that urinary incontinence is associated with disability, ...

Core-shell ‘chemical looping’ boosts efficiency of greener approach to ethylene production

Core-shell ‘chemical looping’ boosts efficiency of greener approach to ethylene production
2024-01-12
Ethylene is sometimes called the most important chemical in the petrochemical industry because it serves as the feedstock for a huge range of everyday products. It’s used in the production of antifreeze, vinyl, synthetic rubber, foam insulation, and plastics of all kinds.  Currently, ethylene is produced through an energy- and resource-intensive process called steam cracking, where extremes of temperature and pressure produce ethylene from crude oil in the presence of steam—and in the process, emit tons of carbon dioxide into the atmosphere. Another way ...

LAST 30 PRESS RELEASES:

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

[Press-News.org] Healthy Hearts for Women event marks 10 years of raising awareness